Cargando…
Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
SIMPLE SUMMARY: The insulin-like growth factor-1 receptor (IGF1R) is a receptor commonly overexpressed and overactivated in a variety of cancers, including Ewing sarcoma, and promotes cell growth and survival. After promising results with targeting and inhibiting the receptor in vitro, multiple diff...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759976/ https://www.ncbi.nlm.nih.gov/pubmed/33260481 http://dx.doi.org/10.3390/cancers12123568 |